Provided by Tiger Fintech (Singapore) Pte. Ltd.

ADC Therapeutics SA

1.73
-0.1100-5.98%
Post-market: 1.730.00000.00%16:05 EDT
Volume:281.20K
Turnover:493.59K
Market Cap:167.27M
PE:-0.75
High:1.83
Open:1.81
Low:1.69
Close:1.84
Loading ...
Dec 08, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Sep 14, 2022

Correspondence

CORRESP [Cover] - Correspondence
Sep 14, 2022

Correspondence

CORRESP [Cover] - Correspondence
Jun 30, 2022

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Mar 17, 2022

Annual Report

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Aug 03, 2021

important event

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
May 06, 2021

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Apr 12, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Mar 18, 2021

important event

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Mar 18, 2021

Annual Report

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
Mar 18, 2021

important event

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Mar 11, 2021

important event

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Feb 25, 2021

important event

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Feb 16, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals